We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Eye Implant Stimulates Vision-Restoring Progress

By HospiMedica International staff writers
Posted on 15 Aug 2012
A novel eye implant provides electrical stimulation of the retina that can improve visual perception in blind people with severe to profound retinitis pigmentosa (RP).

The Argus II Retinal Prosthesis System includes an antenna, an electronics case, and an electrode array, and was designed to bypass damaged photoreceptors altogether. More...
The system is based on a video camera set in special glasses that captures a scene. The video is sent to a small patient-worn computer video processing unit (VPU), where it is transformed into excitation instructions sent back to the glasses via a cable. These instructions are then transmitted wirelessly to the antenna in the implant, which passes them to a 60-electrode grid that is surgically implanted and attached to the retina array.

The retina array emits small pulses of electricity that bypass the damaged photoreceptors and stimulate the retina’s remaining cells, which transmit the visual information along the optic nerve to the brain. Patients then learn to interpret these visual patterns, thereby regaining some functional vision. Users of the Argus II bionic eye report that the system helps them perceive rough shapes and track the movement of objects, and that they can slowly read large writing. The result delivers greater independence for patients. The Argus II Retinal Prosthesis System is a product of Second Sight (Sylmar, CA, USA).

“I started to work on retinal implants more than fifteen years ago here in Germany because I knew we could and we should help blind patients suffering from retinitis pigmentosa,” said Prof. Peter Walter, MD, of the Universitäts-Augenklinik RWTH (Aachen, Germany), one of three surgeons in Germany to have implanted Argus II in patients to date. “Today with Argus II, we can finally offer a treatment to patients backed by many years of safety and performance data.”

RP is an inherited, degenerative eye disease that causes severe vision impairment and blindness. A form of retinal dystrophy, RP is caused by abnormalities of the photoreceptors or the retinal pigment epithelium (RPE) of the retina leading to progressive sight loss. Affected individuals may experience defective light to dark or dark to light adaptation, or nyctalopia, as the result of the degeneration of the peripheral visual field (known as tunnel vision). Sometimes, central vision is lost first causing the person to look sidelong at objects.

Related Links:

Second Sight
Universitäts-Augenklinik RWTH



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.